Ipsen SA (OTCPK:IPSEF)
$ 125.37 0 (0%) Market Cap: 9.63 Bil Enterprise Value: 9.39 Bil PE Ratio: 13.52 PB Ratio: 2.38 GF Score: 90/100

Ipsen SA Expanding the Scope in Rare Disease Investor and Analyst Conference Call Transcript

Dec 17, 2021 / 01:30PM GMT
Release Date Price: $98.19
Operator

Welcome to Ipsen's conference call and webcast on Expanding the Scope in Rare Disease. This call is for investors and analysts. Today's presentation is available on ipsen.com. I now have pleasure in handing over to Ipsen's Chief Executive Officer, David Loew. Please go ahead.

David Loew
Ipsen S.A. - MD, CEO & Director

Good afternoon and good morning everyone. You've just heard, I'm David Loew, Chief Executive Officer of Ipsen. I'm delighted that you have joined today so that we can take you through today's exciting news on our expanding scope in rare disease.

Please turn to Slide 2. This is our safe harbor statement, which outlines the routine risks and uncertainties contained within this presentation.

Turning to Slide 3. I'm joined today by our CFO, Aymeric Le Chatelier; as well as Howard Mayer, Ipsen's Head of Research and Development. We'll begin with a brief presentation before using the majority of the time to answer your questions.

Please turn to Slide 4. I will begin the presentation by taking you through the strategic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot